fda removes semaglutide from drug shortage list february 21 2025 semaglutide no longer available On February 21, 2025, the FDA announced that The Semaglutide Shortage Is Ending:

Behavioural interventions remain foundational , and pharmacotherapy should complement rather than replace lifestyle modifications

See Top Providers What Is a GLP-1

Incretin action plays a large role on post-prandial secretion of insulin, and may account for up to 70% of hormone release (6)

Preventing it requires a plan to manage returning hunger and preserve muscle mass

The discovery recasts inconsistent outcomes and gastrointestinal side effects as part of the same biological narrative, pointing to the medications' own target receptors

Having access to a dedicated team means that if a morning dose isnt working for you, you have the professional support to adjust your plan without stress or confusion